Patients often “drop dead” while feeling completely normal. This collapse happened to my grandfather on July 3rd, 2015 which served as an impetus for me to find a solution to this problem. In these “silent” cases, doctors are unlikely to administer the crucial FABP3 blood test because there is no visible presentation of symptoms to warrant a diagnostic test. As a result, silent heart attacks go unnoticed.

“I realized that if at-risk patients could test themselves daily for the presence of FABP3 in their blood. They would have higher chances of detecting silent heart attacks as they occur. A method that allows daily self-testing would have to be non-invasive, safe, and easy to use. Ultimately, it would have to involve a transcutaneous blood analysis, which examines the contents of one’s blood without penetrating the skin.

In searching for ways to tackle this challenging prospect. I examined the various distinguishing characteristics of blood proteins that would allow them to be identified transcutaneously. I found that proteins have distinctive masses and electric charges in blood.

So, I used a model to test whether different magnitudes of charged electricity. When applied to a thin area of skin, would isolate FABP3 from the other blood proteins and attract FABP3 to the capillary walls. My results showed that this is true.

This means that the technique that I investigated can potentially be coupled with transcutaneous UV-protein quantification to non-invasively measure the amount of FABP3 in a patient’s blood and alert him or her of a silent heart attack.”

Help Million Hearts Stay Healthy! Is his web page that narrates his vision.

He was frequenting scientific conventions to further his knowledge in the science field. Internet gave him a lot of insight, he admits Clinical trials for the medical device are on. And it could be approved for a human trial. The product would be fit to be launched in the market after two months of human trial, assuming nothing goes wrong.

“I have already filed for a patent and I would tie up with the department of biotechnology for the trial. I would want the Government of India to take the project instead of selling it to a private company because it is for the public good,” he says on his website.

To monitor, regular use small silicon patch stuck to your wrist or back of your ear. Whether there has been a heart attack instead of waiting for a doctor to prescribe a test.

The patch uses a positively charged electrical impulse to draw negatively charged —protein to the surface; If the amount of FABP3 is high, then the person would need immediate medical attention; Experts recommend to use the device twice a day. The product can soon be in the market. It would cost around R 900, cheaper than a glucometer symptoms at all.

Diabetes, high blood pressure, high cholesterol levels all put you at risk of a silent heart attack, experts say. Having a silent heart attack puts people at a greater risk of having another heart attack, which could be fatal. Having another heart attack also increases the risk of complications, such as heart failure.

Chest pain, pain in the left arm or shortness is when of breath characterizes a silent heart attack. A silent heart attack may not show symptoms of chest pain and shortness of breath that doesn’t feel heart attack. Akash aims to study cardiology at the country’s premier All India Institute of Medical Sciences in Delhi.

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

Bharat Biotech Ltd. has won the award for taking to the market a vaccine for rotavirus disease. The vaccine, Rotavac, is currently licensed in two countries, while the grant of license is under process in 30 other countries. It has also been prequalified by the World Health Organisation (WHO), making it eligible for procurement by UN and other humanitarian organizations for their public health vaccine programmes.

Agappe Diagnostics Ltd. has won the award for commercializing an automated cartridge-based specific protein analyzer. The instrument has become highly popular as it is smaller and cheaper compared to similar machines available from multinational companies.

The President presented the awards to mark the 20th National Technology Day.

He also gave away national awards to five medium and small-scale enterprises for commercializing indigenous technologies. The winners are Synkromax Biotech, ANTS Ceramics, 3B Blackbio Biotech, Envision Scientific and Hind High Vacuum.

Synkromax got the award for marketing a life-saving implant developed by IIT Madras, while ANTS Ceramics got the award for commercializing high-end zirconia ceramic products and carbon sulphur analysis crucibles and 3B National Technology Awards presented Blackbio Biotech for working on a kit for diagnosis and prognosis of chronic myeloid leukemia.

Envision Scientific got the award for commercializing an indigenously developed drug eluting stent for diabetic patients and Hind High Vacuum got for commercializing thin film metallized alumina circuit for space applications.

Three start-ups got award for developing technologies that have commercial potentials – Astrome Technologies at the Indian Institute of Science, Bengaluru, for its work on GigaMesh, which is said to be the first point to multi-point millimeter wave wireless communication solution in the world; CyCa Onco Solutions at Kalinga Institute of Industrial Technology, Bhubaneswar, for developing two drug delivery devices for delivery of anticancer drug, Crisplatin; and Xcellence in Bio Innovation and Technologies at BITS Pilani Hyderabad campus, for developing a point of care device for testing antibiotic sensitive of pathogens causing urinary tract infections.

Speaking on the occasion, the President noted that the National Technology Day was landmark day for the country as it was on this day two decades ago that the Pokhran nuclear tests took place and demonstrated India’s capacity as a nuclear weapons state as well as a mature and responsible technology power, capable of harnessing sensitive knowledge.

He said technology was a destiny for the country as all national programmes required a force multiplier in the form of technology. But, at the same time, it must also be about equity. “Its (technology’s) fruits must be accessible to all. Finance and resources should be available to all technologists who may wish to turn entrepreneurs – and to migrate from the lab room to the shop floor.” Above all, the President said, gender equity must be integrated with technology production and technology sharing.